Clinical Trials Medtech - January 9, 2018
Acarix initiates multi-center trial
The company has initiated a multi-center trial of its CADScor System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease. The results from the study are expected to be available early 2020. Acarix believes the device has the potential to both improve triaging of patients and reduce the need for costly further invasive diagnostic investigations. […]
Pharma Business - June 14, 2017
Acarix receives commercial order for CADScorSystem
Herning Hospital has placed the first commercial order for the CADScorSystem for non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD). The CADScorSystem combines acoustic detection of turbulent arterial flow and myocardial movement with advanced algorithms in a handheld device to provide a patient specific CAD-score in less than 10 minutes. “Despite the availability of […]
MedTech Award - May 12, 2017
Acarix awarded Design award
Swedish/Danish medical device company Acarix has won the Danish Design Award in the category Employment Growth. The award is a recognition of Acarix and its CADScor System’s potential for outstanding international success and employment growth. Since going public on Nasdaq First North Premier in Stockholm in December 2016, the company has continued its plans for […]
Pharma Business - December 12, 2016
Well-oversubscribed share issue for Acarix
Acarix has raised SEK 140 million before transaction costs through a well-oversubscribed share issue in connection with the initial public offering listing on Nasdaq First North Premier. The offering was directed to institutional and professional investors as well as to the public in Sweden and Denmark. Due to the large interest, allotment of new shares […]
Listing - November 16, 2016
Acarix to Nasdaq First North
Acarix applies for entry on Nasdaq First North Premier in Stockholm. The capital contribution which the company pertain to obtain in connection to the entry is worth 140 million SEK, already secured through description and garantee undertakings. The capital from the entry will mainly go to the company’s commercialization strategy and their planned launch of […]
Financing - November 8, 2016
Acarix receives double-digit SEK million investment
Acarix, a Swedish/Danish medical device company specializing in non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD), has received a major strategic investment from the Chinese company Puhua Jingxin Guzhou Health Management Partnership (Puhua Jingxin). The aim of the double-digit million investment is to accelerate market introduction of the already CE-marked CADScorSystem. The system combines […]
